Home » Topics » Articles » Insight

Insight
RSS

The week's biggest gainers and losers

July 8, 2019

BioWorld Stock Index 2019

July 8, 2019

Biopharma money raised: Jan. 1 - June 27, 2019

July 8, 2019

Nasdaq Stock Index 2019

July 8, 2019

Biotech money raised by month in 2019 (US$M)

July 8, 2019

Public financing of biotechnology companies: Commenced trading in June 2019

July 8, 2019

Public financing of biotechnology companies: Filed and pending IPOs in June 2019

July 8, 2019

Other financings of public biotechnology companies in June 2019

July 8, 2019

Venture capital and other investments in private biotech companies in June 2019

July 8, 2019

Milestone payments from corporate partners in June 2019

July 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...